Aston Martin Lagonda Global Holdings PLC

Aston Martin revs higher on proposed China car tax changes

The tax cut is only expected to apply to smaller-engine vehicles, but the more positive outlook for the world’s largest car market has also boosted luxury brands such as Ferrari and Aston Martin

aston martin
Chinese car sales fell 13% to 1.9mln units in September

Shares in carmakers including Aston Martin Lagonda Global Holdings PLC (LON:AML) revved higher on Monday on reports that China is considering a tax cut to revive its flagging automotive market.

The proposals would help to prop up the world’s largest car market which is facing its first decline in more than two decades as the recent trade war with the US dents consumer spending. To offset the slowdown, the Chinese government is proposing to halve the tax on car purchases to 5%. Although the cuts are only likely to apply to smaller-engine vehicles like those in Volkswagen and Ford vehicles, luxury carmakers were also riding on the coattails of the uptick in sentiment.

Demand for European supercars is soaring in China, where an estimated two billionaires are ‘created’ every week.

Earlier this year, Aston Martin announced a £600mln investment drive into the country earlier this year to try to take advantage of its growing popularity in the region.

Aston Martin shares were up 2% to 1,440p in later afternoon trading, while in Milan, Ferrari shares were up by a similar percentage.

Quick facts: Aston Martin Lagonda Global Holdings PLC

Price: £4.75

Market: LSE
Market Cap: £1.08 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



BB Healthcare's Paul Major upbeat on the trust's long-term fundamentals

BB Healthcare Trust PLC (LON:BBH) is a healthcare trust focused on global healthcare equities.  It is run by the management team behind the successful BB Biotech Investment Trust. Portfolio manager Paul Major says while things may be tough for healthcare investors right now, he's...

41 minutes ago

2 min read